LAKE COUNTY, Fla., March 20, 2018 /PRNewswire/ -- Prostate Evaluation Center announced today that founder Dr. James Young is the first urologist in the U.S. to treat 500 patients with the Rez?m® System, a revolutionary, safe and effective minimally invasive treatment option for men suffering from BPH that does not require general anesthesia and provides an alternative to a lifetime of taking BPH medications. Dedicated to bringing new minimally invasive therapies to his patients, Dr. Young, a board-certified urologist, offers Rez?m as an office-based BPH treatment option at the Prostate Evaluation Center in Lake County, Fla. Dr. Young has been practicing urology for 35 years and attended medical school at the University of Arkansas. He founded the Prostate Evaluation Center in 1982. According to leading online physician and hospital resource Healthgrades.com, Dr. Young ranks in the top 100th percentile of all urologists in the U.S., based upon hundreds of patient surveys and reviews.
BPH is one of the top 10 most common and costly diseases, affecting 14 million American men aged 50 or older, with nearly one million new diagnoses each year. BPH causes significant quality of life issues including lack of sleep, anxiety, challenges with sexual function and limits to daily activities.
"Having performed 500 treatments with the Rez?m System, it's clear there's a rapidly growing demand for this minimally invasive alternative treatment to surgery or taking daily medications for the rest of their lives," said Dr. Young. "I'm pleased to be able to provide my patients who are suffering from BPH with such an effective first-line therapy that is less invasive than surgical options, and avoids sexual side effects of surgical procedures and medication treatment."
Developed by NxThera, Rez?m is performed in a physician office or outpatient setting. Rez?m uses the natural thermal energy stored in water vapor or steam, to treat the enlarged and obstructive prostate tissue that causes BPH urinary symptoms such as frequency, urgency, irregular flow, weak stream, straining and getting up at night to urinate. The water vapor is delivered into the targeted prostate tissue, and when the vapor contacts the tissue it condenses, releasing the stored thermal energy and causing the obstructive prostate tissue cells to die.
In the weeks following a Rez?m procedure, the body's natural healing response eliminates the treated tissue, shrinking the prostate. As the obstructive tissue is removed, the urethra opens back up, reducing BPH symptoms and improving the patient's quality of life and ability to urinate, while preserving sexual function. Studies have shown that the Rez?m treatment provides durable symptom relief and allows men to retain sexual function unlike surgical BPH treatments, which typically have higher incidences of long-term sexual side effects. To date, more than 22,000 men have been effectively treated with the Rez?m System across the U.S. and Europe.
"The Rez?m System is transforming the standard of care for patients who suffer from BPH," said Bob Paulson, president and CEO of NxThera. "Dr. Young is leading the way in providing patients with a minimally invasive and cost-effective option to improve their symptoms so they can get back to enjoying a better quality of life."
Highlights of the Rez?m therapy include:
For more information about Prostate Evaluation Center, visit www.prostateevaluation.com. For more information about the Rez?m System, visit www.Rez?m.com or call 888-319-9691.
About Prostate Evaluation Center
Dr. James Young founded Prostate Evaluation Center (previously Urology Associates of Lake County) in 1982 to address the general urology needs of the area. Since then, Dr. Young has chosen to focus on men's health problems including prostate and erectile dysfunction issues. Diagnostic services available within the office include PSA and transrectal ultrasound to diagnose prostate cancer as well as urodynamics and cystoscopy to evaluate bladder problems. In-office treatments include therapies for enlarged prostates (BPH).
About NxThera and the Rez?m System
NxThera pioneered its Convective Water Vapor Energy (WAVE®) platform technology to treat a variety of endourological conditions, beginning with BPH. The company is conducting advanced development and clinical research to potentially expand application of its technology to include the targeted treatment of cancerous prostate, kidney and bladder tissue as well as OAB. NxThera's FDA-cleared Rez?m System is indicated to treat symptoms of BPH using thermal energy that is convectively delivered to obstructive prostate tissue in targeted, precise treatments, with minimal discomfort. Three-year clinical data demonstrates sustained improvements in LUTS, urine flow, quality of life, and preservation of sexual function. Founded in 2008, NxThera is located in Maple Grove, Minn. For more information, visit www.rezum.com.
Advertisement
BPH is one of the top 10 most common and costly diseases, affecting 14 million American men aged 50 or older, with nearly one million new diagnoses each year. BPH causes significant quality of life issues including lack of sleep, anxiety, challenges with sexual function and limits to daily activities.
Advertisement
"Having performed 500 treatments with the Rez?m System, it's clear there's a rapidly growing demand for this minimally invasive alternative treatment to surgery or taking daily medications for the rest of their lives," said Dr. Young. "I'm pleased to be able to provide my patients who are suffering from BPH with such an effective first-line therapy that is less invasive than surgical options, and avoids sexual side effects of surgical procedures and medication treatment."
Developed by NxThera, Rez?m is performed in a physician office or outpatient setting. Rez?m uses the natural thermal energy stored in water vapor or steam, to treat the enlarged and obstructive prostate tissue that causes BPH urinary symptoms such as frequency, urgency, irregular flow, weak stream, straining and getting up at night to urinate. The water vapor is delivered into the targeted prostate tissue, and when the vapor contacts the tissue it condenses, releasing the stored thermal energy and causing the obstructive prostate tissue cells to die.
In the weeks following a Rez?m procedure, the body's natural healing response eliminates the treated tissue, shrinking the prostate. As the obstructive tissue is removed, the urethra opens back up, reducing BPH symptoms and improving the patient's quality of life and ability to urinate, while preserving sexual function. Studies have shown that the Rez?m treatment provides durable symptom relief and allows men to retain sexual function unlike surgical BPH treatments, which typically have higher incidences of long-term sexual side effects. To date, more than 22,000 men have been effectively treated with the Rez?m System across the U.S. and Europe.
"The Rez?m System is transforming the standard of care for patients who suffer from BPH," said Bob Paulson, president and CEO of NxThera. "Dr. Young is leading the way in providing patients with a minimally invasive and cost-effective option to improve their symptoms so they can get back to enjoying a better quality of life."
Highlights of the Rez?m therapy include:
- Performed in the physician office; patients can return home immediately.
- Does not require general anesthesia.
- Relieves symptoms safely and effectively.
- Is an alternative to BPH medications, eliminating the need for long-term BPH medication use.
- Provides noticeable symptom improvement within two weeks.
- Preserves erectile and urinary functions.
- Allows patients to return to regular activities within a few days.
- Considered medically necessary by Medicare and reimbursed by many private insurance payers.
For more information about Prostate Evaluation Center, visit www.prostateevaluation.com. For more information about the Rez?m System, visit www.Rez?m.com or call 888-319-9691.
About Prostate Evaluation Center
Dr. James Young founded Prostate Evaluation Center (previously Urology Associates of Lake County) in 1982 to address the general urology needs of the area. Since then, Dr. Young has chosen to focus on men's health problems including prostate and erectile dysfunction issues. Diagnostic services available within the office include PSA and transrectal ultrasound to diagnose prostate cancer as well as urodynamics and cystoscopy to evaluate bladder problems. In-office treatments include therapies for enlarged prostates (BPH).
About NxThera and the Rez?m System
NxThera pioneered its Convective Water Vapor Energy (WAVE®) platform technology to treat a variety of endourological conditions, beginning with BPH. The company is conducting advanced development and clinical research to potentially expand application of its technology to include the targeted treatment of cancerous prostate, kidney and bladder tissue as well as OAB. NxThera's FDA-cleared Rez?m System is indicated to treat symptoms of BPH using thermal energy that is convectively delivered to obstructive prostate tissue in targeted, precise treatments, with minimal discomfort. Three-year clinical data demonstrates sustained improvements in LUTS, urine flow, quality of life, and preservation of sexual function. Founded in 2008, NxThera is located in Maple Grove, Minn. For more information, visit www.rezum.com.
View original content:http://www.prnewswire.com/news-releases/prostate-evaluation-centers-dr-james-young-is-first-in-us-to-reach-milestone-of-treating-500-patients-with-rezm-system-minimally-invasive-office-based-bph-therapy-300616529.html
SOURCE Prostate Evaluation Center
